Summit Global Investments Makes New $1.13 Million Investment in Relx Plc (NYSE:RELX)

Summit Global Investments bought a new stake in shares of Relx Plc (NYSE:RELX - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 22,414 shares of the technology company's stock, valued at approximately $1,130,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. CENTRAL TRUST Co raised its holdings in shares of Relx by 1,290.2% during the fourth quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock valued at $26,000 after purchasing an additional 529 shares during the last quarter. Transce3nd LLC purchased a new stake in Relx during the 4th quarter valued at $40,000. Sierra Ocean LLC purchased a new stake in Relx during the 4th quarter valued at $43,000. Brown Brothers Harriman & Co. lifted its holdings in shares of Relx by 218.5% during the 4th quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock valued at $44,000 after buying an additional 662 shares during the period. Finally, Private Trust Co. NA lifted its holdings in shares of Relx by 19.2% during the 4th quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock valued at $56,000 after buying an additional 199 shares during the period. Institutional investors own 15.02% of the company's stock.

Relx Stock Performance

Relx stock traded up $0.47 during trading on Wednesday, reaching $54.53. The company had a trading volume of 1,162,785 shares, compared to its average volume of 724,122. The firm's 50-day simple moving average is $52.45 and its 200 day simple moving average is $49.57. Relx Plc has a 52 week low of $43.45 and a 52 week high of $56.33. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. The firm has a market capitalization of $100.66 billion, a price-to-earnings ratio of 29.32, a price-to-earnings-growth ratio of 2.73 and a beta of 0.86.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. Barclays upgraded Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. The Goldman Sachs Group started coverage on Relx in a research note on Wednesday, March 26th. They set a "buy" rating for the company. Wall Street Zen cut shares of Relx from a "buy" rating to a "hold" rating in a research note on Tuesday, March 4th. Finally, Morgan Stanley reissued an "overweight" rating on shares of Relx in a report on Wednesday, April 16th. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Buy".

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.